Адель Альбертович Измайлов
Ministry of Health of the Russian Federation · 186 works · 1,686 citations · h-index 12
Top works
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
- Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney
- Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
- The opportunities and challenges of telemedicine during COVID-19 pandemic
- The current state of MiRNAs as biomarkers and therapeutic tools
- Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent
- Method of calculating bed capacity of surgical departments of cancer centers according to the morbidity rates in the Russian Federation regions
- The Role of Long Non-Coding RNAs in Intracranial Aneurysms and Subarachnoid Hemorrhage
- Diagnostic and prognostic potential of circulating miRNAs for intracranial aneurysms
- DNA repair XPCC1 and XPD genes polymorphism as associated with the development of bladder cancer and renal cell carcinoma
- Peritoneal Carcinomatosis: Current State of the Art and Schools of Thought
- Comparative analysis of adverse events using different methods of prostate biopsy
- Analysis of the results of ERAS protocol in real-life clinical practice AFTER radical cystectomy (the first prospective multicenter study in Russia)
- Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
- Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events
- MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients
- Predictors of Multiple Primary Malignancies: Literature Review
- Mechanisms of Formation of Specific Antitumor Immunity and Resistance to Immune Checkpoint Inhibitors
- Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study